Results 181 to 190 of about 5,990 (215)
Some of the next articles are maybe not open access.

An analytical pharmacodynamic model for nondepolarizing neuromuscular blocking agents

Journal of Pharmacokinetics and Biopharmaceutics, 1981
A pharmacodynamic model for nondepolarizing neuromuscular blocking agents (NMBA) is developed and tested with different sets of data (NMBA plasma concentration and time evolution of muscular paralysis). This model takes into account the binding of NMBA to the cholinergic motor endplate receptors and thus permits estimation of the apparent equilibrium ...
D'Hollander, Alain, Delcroix, Claude
openaire   +3 more sources

Effect of Lignocaine on the Responses Produced by Depolarizing Agents at the Chick Neuromuscular Junction

Acta Anaesthesiologica Scandinavica, 1984
The effect of lignocaine on the depolarization and contracture responses produced by acetylcholine (ACh) or tetraethylammonium (TEA) was studied in the isolated chick biventer cervicis (BVC) nerve‐muscle preparation using the moving fluid electrode technique.
openaire   +2 more sources

Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans.

Arzneimittel-Forschung, 1982
The pharmacokinetics of 2 beta, 16 beta-bis-(4'-dimethyl-1'-piperazino)-3 alpha, 17 beta-diacetoxy-5 alpha-androstane dibromide (pipecurium bromide, Arduan), a new non-depolarizing neuromuscular blocking agent, was studied in surgical patients. Plasma concentration-time curves of pipecurium bromide were evaluated by fitting the data to a bi-exponential
E, Tassonyi, G, Szabó, L, Vereczkey
openaire   +1 more source

Determination of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum.

Arzneimittel-Forschung, 1981
A method for the determination of 2 beta, 16 beta-bis (4'dimethyl-1'-piperazino)-3a, 17 beta-diacetoxy-5 alpha-androstane is described. After deproteinization a pipecurium bromide Rose Bengal complex is formed and extracted with chloroform from a mildly basic medium.
G, Szabó, E, Tassonyi
openaire   +1 more source

Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.

Acta anaesthesiologica Sinica, 1998
Rocuronium is a new nondepolarizing muscle relaxant. It features a rapid onset and lack of histamine release: It has an intermediate onset of action as vecuronium. The purpose of this study was to compare the neuromuscular action and condition of intubation after a bolus dose of rocuronium or vecuronium (2 x ED90).
P L, Lin   +5 more
openaire   +1 more source

DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND INTRAOCULAR PRESSURE IN VIVO

Anesthesiology, 1957
J B, DILLON   +3 more
openaire   +2 more sources

Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide.

European journal of anaesthesiology. Supplement, 1994
The safety of neuromuscular relaxants can be assessed according to their cardiovascular and autonomic effects, their liability to release histamine, their tendency to cause anaphylactic/anaphylactoid reactions, their effect on cholinesterase, on intra-ocular and intracranial pressure, their tendency to cumulation and their reversibility.
openaire   +1 more source

The Interaction Between Suxamethonium and the Succeeding Non-Depolarizing Neuromuscular Blocking Agent

Survey of Anesthesiology, 1991
J. SWEN   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy